<DOC>
	<DOCNO>NCT01537250</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability population pharmacokinetics oral nemonoxacin community-acquired pneumonia ( CAP ) subject .</brief_summary>
	<brief_title>Phase II Clinical Study Assess Efficacy Safety Nemonoxacin Malate Treating Adult Patients With Community-acquired Pneumonia ( CAP )</brief_title>
	<detailed_description>Evaluate clinical efficacy , microbiological efficacy safety Nemonoxacin adult patient community-acquired pneumonia ( CAP ) ; A study population pharmacokinetics ( PPK ) continuous oral administration Nemonoxacin adult patient CAP .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>1. age 18~70 , BMI â‰¥ 18 kg/m2 2 . Female patient must avoid pregnancy 3 . Patients clinically diagnose communityacquired pneumonia ( CAP ) 4 . Chest Xray show inflammatory exudation infiltration image . 5 . Patients used antibacterial agent ( exclude quinolones ) within 72 hour 6 . The patient 's disease condition permit oral administration 1 . Patients bronchiectasis pulmonary disease . 2 . Hospitalized within 14 day enrollment 3 . Have history allergy quinolone fluoroquinolone antibiotic 4 . Patients suffer uncontrolled mental disorder , epilepsy central nervous system disease . 5 . Renal , liver insufficiency 6 . Malabsorption syndrome gastrointestinal disease 7 . Immune system disease , history human immunodeficiency virus ( HIV ) infection , neutropenia malignant tumor blood system solid organ , removal spleen 8 . Steroids longterm use , dose least 20mg prednisone daily 9 . Patients critical condition . 10 . Shows significant abnormality cardiac conduction system ( CCS ) abnormality , prolong QTc 11 . Have medical history prolong QTc , require concomitant medication drug lead prolongation QTc 12 . Patients receive chemotherapy antitumor therapy within 6 month 13 . Alcohol abuse drug ban 14 . Patients used quinolones within two week enrollment 15 . Donated 500ml blood within 3 month 16. comedication antibacterial agent require . 17. investigator judgement , patient increase risk subject interfere clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>CAP</keyword>
</DOC>